Jabre Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-30,000
| Closed | -$2.83M | – | 133 |
|
|
2018
Q2 | $2.83M | Buy |
+30,000
| New | +$2.83M | 0.19% | 34 |
|
|
2017
Q4 | – | Sell |
-45,000
| Closed | -$4.19M | – | 100 |
|
|
2017
Q3 | $4.19M | Buy |
+45,000
| New | +$4.19M | 0.81% | 47 |
|
|
2015
Q2 | – | Sell |
-35,000
| Closed | -$4.07M | – | 89 |
|
|
2015
Q1 | $4.07M | Buy |
+35,000
| New | +$4.07M | 0.38% | 59 |
|
|
2014
Q4 | – | Sell |
-75,000
| Closed | -$4.98M | – | 92 |
|
|
2014
Q3 | $4.98M | Sell |
75,000
-731,355
| -91% | -$48.5M | 0.43% | 65 |
|
|
2014
Q2 | $50.2M | Buy |
806,355
+540,855
| +204% | +$33.6M | 3.53% | 2 |
|
|
2014
Q1 | $16.9M | Buy |
+265,500
| New | +$16.9M | 1.62% | 14 |
|